Kang Tianyi

Dr. Tianyi Kang is a Research Assistant Professor in the Department of Biomedical Engineering at the College of Engineering, Southern University of Science and Technology (SUSTech). She joined SUSTech in 2019 after completing her Ph.D. at Sichuan University, where she conducted research at the State Key Lab of Biotherapy. Her work focuses on developing functional nanomaterials for biological imaging and tumor therapy, with emphasis on translational cancer applications.

Her academic credentials include:

• Ph.D. in Biology, Sichuan University (2016-2019)
• M.S. in Pharmaceutical Analysis, Sichuan University (2012-2015)
• B.S. in Traditional Chinese Medicine, Chengdu University of TCM (2008-2012)

Dr. Kang's research integrates nanotechnology with oncology to address critical cancer treatment challenges. She pioneers photodynamic immunotherapy approaches that combine light-activated compounds with immune system engagement for targeted tumor destruction. Her biomedical imaging work develops nanomaterial-enhanced techniques for early cancer detection, while her exosome research explores natural nanovesicles as drug carriers for precision therapy. This interdisciplinary strategy bridges materials science, immunology, and clinical oncology to create novel therapeutic platforms.

Analysis of her nine publications (2015-2021) reveals a consistent trajectory in nanomedicine for oncology, featuring high-impact journals like Biomaterials and Angewandte Chemie. Core themes include tumor-specific nanocarrier design, photothermal/photodynamic therapy optimization, and biomimetic systems for immune modulation. Recent work emphasizes microRNA delivery via photoacoustic forces and molecular motors for photothermal conversion, highlighting innovation in spatiotemporal control of therapeutic agents. Subfield trends show increasing focus on combination therapies that enhance efficacy while reducing systemic toxicity.

Her scientific recognition includes:

• Guangdong Provincial Joint Fund for Young Scientists

Dr. Kang secured one Youth Fund project from Guangdong Province and holds an invention patent. Though advising details are unspecified, her faculty role implies graduate student mentorship within SUSTech's Biomedical Engineering Department. Her research likely involves collaboration with Shenzhen clinical partners for translational development. Future work may expand exosome-based immunotherapies and multi-stimuli-responsive nanocarriers.

She operates within SUSTech's Department of Biomedical Engineering, which provides advanced infrastructure for nanomaterial synthesis, in vivo imaging, and preclinical testing. The department's strong industry-academia partnerships in Shenzhen enable rapid prototyping and clinical validation of novel cancer therapeutics.